Skip to main content
. 2000 Apr;44(4):985–990. doi: 10.1128/aac.44.4.985-990.2000

TABLE 1.

Volume of ELF and AC counts at six time periods following drug administration

Characteristic 4 h 5 h 7 h 12 h 24 h 48 h
Total cell count in BAL fluida (cells/liter) 1.31 × 108 ± 7.57 × 107 1.72 × 108 ± 1.18 × 108 1.41 × 108 ± 1.71 × 108 9.94 × 107 ± 1.60 × 107 8.52 × 107 ± 2.67 × 107 9.30 × 107 ± 6.62 × 107
 Neutrophilsa (%) 1.0 ± 1.2 1.6 ± 0.9 0.8 ± 0.8 0.8 ± 0.8 1.0 ± 1.0 1.4 ± 1.1
 Lymphocytes (%) 11.2 ± 8.6 11.4 ± 6.8 22.6 ± 10.8 8.8 ± 5.7 9.0 ± 8.6 18.4 ± 10.3
 Monocytes/macrophages (%) 86.0 ± 11.8 84.6 ± 7.6 76.2 ± 11.7 84.8 ± 9.5 89.6 ± 9.0 70.8 ± 21.7
 Eosinophils (%) 0.8 ± 1.8 1.4 ± 2.2 0.4 ± 0.9 2.0 ± 4.5 0.4 ± 0.5 0.4 ± 0.5
 Degenerated cells (%) 1.0 ± 2.2 1.0 ± 2.2 0.0 ± 0.0 3.6 ± 8.0 0.0 ± 0.0 9.0 ± 11.6
ELF vola (ml) 0.82 ± 0.63 1.00 ± 0.35 1.21 ± 0.57 0.98 ± 0.39 1.13 ± 1.19 0.81 ± 0.48
BAL volb (ml) 71 ± 8.2 79.8 ± 7.4 77 ± 7.2 77.6 ± 3.0 78.2 ± 11.7 79.8 ± 7.5
a

The differences in AC count, differential cell count, or ELF volume among the six groups were not significant (P > 0.05). 

b

Mean ± SD for pooled volume of BAL fluid recovered.